CUK Tri-Axis Balanced Series III-IV

Mentha × piperita

Peppermint

Tier IIICUK Tri-Axis Balanced Series

Target Trait

1.75×

fold-change

Cooling+Umami+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01964

Genomic Edits

GC Content

43.9%

Construct Length

5,447 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPM8 + mGluR1 + CaSR

IFI Score

175

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CUK pathway operation
Cross-pathway regulatory circuit for balanced CUK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (CUK) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier III CUK triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities